Sulindac-derived retinoid X receptor-α modulator attenuates atherosclerotic plaque progression and destabilization in ApoE−/− mice

21Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background and Purpose: Atherosclerosis is a chronic inflammatory disease, and retinoid X receptor-α (RXRα) is an intriguing anti-atherosclerosis target. This study investigated whether and how an RXRα modulator, K-80003, derived from a non-steroidal anti-inflammatory drug attenuates atherosclerotic plaque progression and destabilization. Experimental Approach: Our previously established ApoE−/− mouse model of carotid vulnerable plaque progression was treated with K-80003 or vehicle for 4 or 8 weeks. Samples of carotid arteries and serum were collected to determine atherosclerotic lesion size, histological features, expression of related proteins, and lipid profiles. In vitro studies were carried out in 7-ketocholesterol (7-KC)-stimulated macrophages treated with or without K-80003. Key Results: K-80003 significantly reduced lesion size, plaque rupture, macrophage infiltration, and inflammatory cytokine levels. Plaque macrophages positive for nuclear p65 (RelA) NF-κB subunit were markedly reduced after K-80003 treatment. Also, K-80003 treatment inhibited 7-KC-induced p65 nuclear translocation, IκBα degradation, and transcription of NF-κB target genes. In addition, K-80003 inhibited NF-κB pathway mainly through the reduction of p62/sequestosome 1 (SQSTM1), probably due to promotion of autophagic flux by K-80003. Mechanistically, cytoplasmic localization of RXRα was associated with decreased autophagic flux. Increasing cytoplasmic RXRα expression by overexpression of RXRα/385 mutant decreased autophagic flux in RAW264.7 cells. Finally, K-80003 strongly inhibited 7-KC-induced RXRα cytoplasmic translocation. Conclusions and Implications: K-80003 suppressed atherosclerotic plaque progression and destabilization by promoting macrophage autophagic flux and consequently inhibited the p62/SQSTM1-mediated NF-κB proinflammatory pathway. Thus, targeting RXRα-mediated autophagy-inflammation axis by its noncanonical modulator may represent a promising strategy to treat atherosclerosis.

References Powered by Scopus

Antiinflammatory therapy with canakinumab for atherosclerotic disease

6753Citations
N/AReaders
Get full text

NF-κB: A key role in inflammatory diseases

3627Citations
N/AReaders
Get full text

Animal research: Reporting in vivo experiments: The ARRIVE guidelines

3197Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Macrophage Plasticity and Atherosclerosis Therapy

124Citations
N/AReaders
Get full text

Araloside C attenuates atherosclerosis by modulating macrophage polarization via Sirt1-mediated autophagy

73Citations
N/AReaders
Get full text

7-Ketocholesterol and 7β-hydroxycholesterol: In vitro and animal models used to characterize their activities and to identify molecules preventing their toxicity

60Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Shen, L., Sun, Z., Nie, P., Yuan, R., Cai, Z., Wu, C., … He, B. (2019). Sulindac-derived retinoid X receptor-α modulator attenuates atherosclerotic plaque progression and destabilization in ApoE−/− mice. British Journal of Pharmacology, 176(14), 2559–2572. https://doi.org/10.1111/bph.14682

Readers over time

‘19‘20‘2102468

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 7

78%

Professor / Associate Prof. 1

11%

Researcher 1

11%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 4

50%

Agricultural and Biological Sciences 2

25%

Nursing and Health Professions 1

13%

Neuroscience 1

13%

Save time finding and organizing research with Mendeley

Sign up for free
0